Regression Models | aOR | 95% CI | P |
---|---|---|---|
COVID-19 Diagnosis | |||
Younger Age | 0.98 | 0.964–0.994 | 0.006 |
Male Sex | 1.7 | 1.093–2.701 | 0.019 |
Lower eGFR as study start | 0.99 | 0.978–0.998 | 0.020 |
Vaccination 3 + doses | 0.48 | 0.287–0.796 | 0.005 |
COVID-19 Hospitalisation | |||
Older Age | 1.0 | 1.007–1.092 | 0.021 |
eGFR at study start | 0.96 | 0.934–0.982 | < 0.001 |
Deceased donor graft | 4.1 | 1.128–14.747 | 0.032 |
COVID-19 Mortality | |||
Older Age | 1.1 | 1.004–1.192 | 0.040 |
Respiratory disease | 14.2 | 1.825–110.930 | 0.011 |
Current and Former Smoker | 8.2 | 1.020-65.649 | 0.048 |
Vaccination 3 + doses | 0.6 | 0.007–0.523 | 0.011 |
Seroconversion Subgroup | |||
COVID-19 Diagnosis | |||
Asian place of birth | 9.0 | 1.803–44.888 | 0.007 |
Higher Dose of prednisolone | 1.5 | 1.125–1.949 | 0.005 |
Seroconversion | 0.1 | 0.025–0.627 | 0.011 |